Atria Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.7M | Sell |
47,583
-4,741
| -9% | -$1.69M | 0.19% | 100 |
|
|
2025
Q4 | $17.1M | Buy |
52,324
+10,877
| +26% | +$3.45M | 0.19% | 99 |
|
|
2025
Q3 | $11.7M | Sell |
41,447
-4,625
| -10% | -$1.34M | 0.13% | 158 |
|
|
2025
Q2 | $12.9M | Sell |
46,072
-3,848
| -8% | -$1.09M | 0.15% | 136 |
|
|
2025
Q1 | $15.6M | Buy |
49,920
+5,308
| +12% | +$1.57M | 0.2% | 104 |
|
|
2024
Q4 | $11.6M | Sell |
44,612
-2,435
| -5% | -$722K | 0.14% | 162 |
|
|
2024
Q3 | $15.2M | Sell |
47,047
-2,675
| -5% | -$875K | 0.19% | 114 |
|
|
2024
Q2 | $15.5M | Buy |
49,722
+2,130
| +4% | +$626K | 0.2% | 101 |
|
|
2024
Q1 | $13.5M | Sell |
47,592
-5,014
| -10% | -$1.47M | 0.19% | 119 |
|
|
2023
Q4 | $15.1M | Buy |
52,606
+1,425
| +3% | +$388K | 0.23% | 96 |
|
|
2023
Q3 | $13.8M | Buy |
51,181
+11,565
| +29% | +$2.89M | 0.24% | 83 |
|
|
2023
Q2 | $8.8M | Buy |
39,616
+2,517
| +7% | +$584K | 0.16% | 150 |
|
|
2023
Q1 | $8.97M | Sell |
37,099
-3,826
| -9% | -$939K | 0.17% | 148 |
|
|
2022
Q4 | $10.7M | Sell |
40,925
-5,060
| -11% | -$1.36M | 0.22% | 102 |
|
|
2022
Q3 | $10.4M | Buy |
45,985
+7,284
| +19% | +$1.77M | 0.23% | 99 |
|
|
2022
Q2 | $9.42M | Sell |
38,701
-271
| -0.7% | -$66.4K | 0.2% | 114 |
|
|
2022
Q1 | $9.42M | Buy |
38,972
+2,528
| +7% | +$581K | 0.17% | 152 |
|
|
2021
Q4 | $8.2M | Sell |
36,444
-1,715
| -4% | -$362K | 0.15% | 167 |
|
|
2021
Q3 | $8.11M | Buy |
38,159
+760
| +2% | +$175K | 0.15% | 155 |
|
|
2021
Q2 | $9.12M | Buy |
37,399
+2,302
| +7% | +$566K | 0.18% | 130 |
|
|
2021
Q1 | $8.73M | Sell |
35,097
-4,237
| -11% | -$1.01M | 0.19% | 122 |
|
|
2020
Q4 | $9.04M | Buy |
39,334
+673
| +2% | +$155K | 0.22% | 113 |
|
|
2020
Q3 | $9.83M | Buy |
38,661
+8,006
| +26% | +$1.98M | 0.3% | 77 |
|
|
2020
Q2 | $7.23M | Sell |
30,655
-5,092
| -14% | -$1.16M | 0.25% | 97 |
|
|
2020
Q1 | $7.25M | Buy |
35,747
+252
| +0.7% | +$55K | 0.56% | 43 |
|
|
2019
Q4 | $8.56M | Buy |
35,495
+8,234
| +30% | +$1.82M | 0.23% | 97 |
|
|
2019
Q3 | $5.28M | Sell |
27,261
-1,486
| -5% | -$285K | 0.19% | 106 |
|
|
2019
Q2 | $5.83M | Buy |
28,747
+18,874
| +191% | +$3.38M | 0.22% | 100 |
|
|
2019
Q1 | $484K | Sell |
9,873
-8,932
| -47% | -$1.71M | 0.02% | 539 |
|
|
2018
Q4 | $3.66M | Buy |
18,805
+459
| +3% | +$89.5K | 0.16% | 95 |
|
|
2018
Q3 | $3.8M | Buy |
18,346
+653
| +4% | +$129K | 0.15% | 119 |
|
|
2018
Q2 | $3.27M | Sell |
17,693
-1,932
| -10% | -$342K | 0.14% | 130 |
|
|
2018
Q1 | $3.35M | Buy |
19,625
+2
| +0% | +$367 | 0.16% | 119 |
|
|
2017
Q4 | $3.41M | Buy |
19,623
+5,663
| +41% | +$1M | 0.17% | 120 |
|
|
2017
Q3 | $2.6M | Buy |
13,960
+774
| +6% | +$137K | 0.14% | 158 |
|
|
2017
Q2 | $2.27M | Buy |
13,186
+2,484
| +23% | +$404K | 0.14% | 165 |
|
|
2017
Q1 | $1.76M | Buy |
10,702
+3,210
| +43% | +$533K | 0.11% | 193 |
|
|
2016
Q4 | $1.09M | Sell |
7,492
-459
| -6% | -$69.1K | 0.08% | 224 |
|
|
2016
Q3 | $1.33M | Buy |
7,951
+1,244
| +19% | +$210K | 0.12% | 152 |
|
|
2016
Q2 | $1.06M | Sell |
6,707
-175
| -3% | -$27.2K | 0.11% | 161 |
|
|
2016
Q1 | $1.03M | Sell |
6,882
-385
| -5% | -$57.2K | 0.12% | 142 |
|
|
2015
Q4 | $1.09M | Buy |
7,267
+1,317
| +22% | +$207K | 0.12% | 124 |
|
|
2015
Q3 | $823K | Sell |
5,950
-978
| -14% | -$154K | 0.11% | 135 |
|
|
2015
Q2 | $1.06M | Buy |
6,928
+1,182
| +21% | +$189K | 0.12% | 122 |
|
|
2015
Q1 | $918K | Sell |
5,746
-1,690
| -23% | -$266K | 0.1% | 164 |
|
|
2014
Q4 | $1.18M | Sell |
7,436
-209
| -3% | -$32.6K | 0.13% | 132 |
|
|
2014
Q3 | $1.07M | Sell |
7,645
-485
| -6% | -$63.3K | 0.11% | 158 |
|
|
2014
Q2 | $962K | Buy |
8,130
+189
| +2% | +$21.9K | 0.1% | 178 |
|
|
2014
Q1 | $979K | Buy |
7,941
+895
| +13% | +$109K | 0.1% | 170 |
|
|
2013
Q4 | $804K | Buy |
7,046
+7
| +0.1% | +$796 | 0.08% | 213 |
|
|
2013
Q3 | $788K | Buy |
7,039
+1,657
| +31% | +$180K | 0.08% | 209 |
|
|
2013
Q2 | $531K | Buy |
+5,382
| New | +$559K | 0.06% | 172 |
|
Other funds holding AMGN
VCM
VPM
Atria Investments's AMGN Position: Q1 2026 in Review
Atria Investments reduced its Amgen (AMGN) stake by 9.1% in Q1 2026, selling an estimated $1.69M and leaving 47,583 shares worth $16.7M. The position accounts for 0.19% of the portfolio, ranked #100.
Atria Investments first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.1M in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Atria Investments held 47,583 shares of Amgen worth $16.7M as of Q1 2026.
- Atria Investments sold 4,741 Amgen shares in Q1 2026, an estimated $1.69M.
- Amgen made up 0.19% of Atria Investments's portfolio in Q1 2026, its #100 holding.
- Atria Investments first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Atria Investments's Amgen position peaked at $17.1M in Q4 2025.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.